Tumor necrosis factor- alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease
- PMID: 9819375
- PMCID: PMC509139
- DOI: 10.1172/JCI4285
Tumor necrosis factor- alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease
Abstract
Donor T cell responses to host alloantigen are known predictors for graft-versus-host disease (GVHD); however, the effect of donor responsiveness to an inflammatory stimulus such as lipopolysaccharide (LPS) on GVHD severity has not been investigated. To examine this, we used mouse strains that differ in their sensitivity to LPS as donors in an experimental bone marrow transplant (BMT) system. Lethally irradiated (C3FeB6)F1 hosts received BMT from either LPS-sensitive (LPS-s) C3Heb/Fej, or LPS-resistant (LPS-r) C3H/ Hej donors. Mice receiving LPS-r BMT developed significantly less GVHD as measured by mortality and clinical score compared with recipients of LPS-s BMT, a finding that was associated with significant decreases in intestinal histopathology and serum LPS and TNF-alpha levels. When donor T cell responses to host antigens were measured, no differences in proliferation, serum IFN-gamma levels, splenic T cell expansion, or CTL activity were observed after LPS-r or LPS-s BMT. Systemic neutralization of TNF-alpha from day -2 to +6 resulted in decreased intestinal pathology, and serum LPS levels and increased survival after BMT compared with control mice receiving Ig. We conclude that donor resistance to endotoxin reduces the development of acute GVHD by attenuating early intestinal damage mediated by TNFalpha. These data suggest that the responsiveness of donor accessory cells to LPS may be an important risk factor for acute GVHD severity independent of T cell responses to host antigens.
Similar articles
-
Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemia.J Clin Invest. 1999 Aug;104(4):459-67. doi: 10.1172/JCI6896. J Clin Invest. 1999. PMID: 10449438 Free PMC article.
-
IL-2 inhibits early increases in serum gamma interferon levels associated with graft-versus-host-disease.Transplantation. 1994 Dec 27;58(12):1385-93. Transplantation. 1994. PMID: 7809932
-
Hyporesponsiveness of donor cells to lipopolysaccharide stimulation reduces the severity of experimental idiopathic pneumonia syndrome: potential role for a gut-lung axis of inflammation.J Immunol. 2000 Dec 1;165(11):6612-9. doi: 10.4049/jimmunol.165.11.6612. J Immunol. 2000. PMID: 11086106
-
The role of endotoxin and the innate immune response in the pathophysiology of acute graft versus host disease.J Endotoxin Res. 2002;8(6):441-8. doi: 10.1179/096805102125001046. J Endotoxin Res. 2002. PMID: 12697087 Review.
-
Immunobiology of acute graft-versus-host disease.Blood Rev. 2003 Dec;17(4):187-94. doi: 10.1016/s0268-960x(03)00009-2. Blood Rev. 2003. PMID: 14556773 Review.
Cited by
-
Role of Toll-Like Receptor Signaling in the Pathogenesis of Graft-versus-Host Diseases.Int J Mol Sci. 2016 Aug 11;17(8):1288. doi: 10.3390/ijms17081288. Int J Mol Sci. 2016. PMID: 27529218 Free PMC article. Review.
-
Enforced gut homing of murine regulatory T cells reduces early graft-versus-host disease severity.Am J Transplant. 2023 Aug;23(8):1102-1115. doi: 10.1016/j.ajt.2023.01.030. Epub 2023 Mar 4. Am J Transplant. 2023. PMID: 36878433 Free PMC article.
-
Inhibition of IL-32 activation by α-1 antitrypsin suppresses alloreactivity and increases survival in an allogeneic murine marrow transplantation model.Blood. 2011 Nov 3;118(18):5031-9. doi: 10.1182/blood-2011-07-365247. Epub 2011 Sep 6. Blood. 2011. PMID: 21900190 Free PMC article.
-
Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex.Clin Exp Immunol. 2009 Jul;157(1):104-18. doi: 10.1111/j.1365-2249.2009.03933.x. Clin Exp Immunol. 2009. PMID: 19659776 Free PMC article.
-
IL-35 mitigates murine acute graft-versus-host disease with retention of graft-versus-leukemia effects.Leukemia. 2015 Apr;29(4):939-46. doi: 10.1038/leu.2014.310. Epub 2014 Nov 3. Leukemia. 2015. PMID: 25363669 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources